Alan E. Wakeling
Impact in
Papers in
- Co-authors
- Jean Bowler (2 shared papers)Robert I. Nicholson (9 shared papers)Denise Barrow (7 shared papers)Julia M.W. Gee (4 shared papers)Anthony Howell (3 shared papers)Charles Q. Morris (3 shared papers)C. Kent Osborne (2 shared papers)Janice M. Knowlden (2 shared papers)
- Journals
- Breast Cancer Research and Treatment (5 papers)International Journal of Cancer (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Prostaglandins (2 papers)Endocrinology (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Alan E. Wakeling
41 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 101
- Genetics 1.6k
- Oncology 1.1k
- Cancer Research 432
- Toxicology 95
- Endocrinology, Diabetes and Metabolism 357
Countries citing papers authored by Alan E. Wakeling
This map shows the geographic impact of Alan E. Wakeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan E. Wakeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan E. Wakeling more than expected).
Fields of papers citing papers by Alan E. Wakeling
This network shows the impact of papers produced by Alan E. Wakeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan E. Wakeling. The network helps show where Alan E. Wakeling may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan E. Wakeling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 459 | |
| 2 | 2000 | 354 | |
| 3 | 1992 | 223 | |
| 4 | 2002 | 189 | |
| 5 | 1989 | 175 | |
| 6 | Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition. | 2004 | 164 |
| 7 | 2003 | 147 | |
| 8 | 2006 | 129 | |
| 9 | 1993 | 123 | |
| 10 | 1994 | 111 | |
| 11 | 2004 | 105 | |
| 12 | 2004 | 102 | |
| 13 | MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. | 1993 | 95 |
| 14 | 2001 | 93 | |
| 15 | 1983 | 80 | |
| 16 | 1993 | 80 | |
| 17 | 1995 | 79 | |
| 18 | 1974 | 67 | |
| 19 | 1988 | 67 | |
| 20 | 1989 | 63 |
About Alan E. Wakeling
Alan E. Wakeling is a scholar working on Genetics, Oncology, Pharmacology, Molecular Biology and Pharmacology, having authored 42 papers that have together received 3.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (29 papers), HER2/EGFR in Cancer Research (12 papers), Inflammatory mediators and NSAID effects (7 papers), Computational Drug Discovery Methods (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Gene expression and cancer classification (3 papers). The work is most often cited by research in Genetics (1.6k citations), Oncology (1.1k citations), Cancer Research (432 citations), Toxicology (95 citations) and Endocrinology, Diabetes and Metabolism (357 citations). Alan E. Wakeling has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Jean Bowler, Robert I. Nicholson, Denise Barrow, Julia M.W. Gee, Anthony Howell, Charles Q. Morris, C. Kent Osborne, Janice M. Knowlden, Tracie‐Ann Madden and Iain R. Hutcheson. Their work appears in journals such as Breast Cancer Research and Treatment, International Journal of Cancer, Cancer Chemotherapy and Pharmacology, Prostaglandins and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.